backShould life sciences companies expect further scrutiny from FDA on direct-to-consumer advertising and promotion? How can in-house teams prepare for increased DOJ enforcement around federal healthcare programs? What are the potential risks and opportunities? How should drug, device and biologic manufacturers leverage artificial intelligence to see around corners and improve patient outcomes?
For answers to these questions and more, join us at our fourth annual California Life Sciences Summit. This full-day program will feature sessions focused on the most critical legal, compliance, regulatory and enforcement developments impacting the life sciences industry.
Attendees will earn CLE credit and enjoy multiple networking opportunities, including a reception following the sessions.
The registration fee for the full program is $95.
For questions, or for information about registration, contact the K&S Events Team.